Real-world efficacy and safety of pembrolizumab in patients with non-small cell lung cancer: a retrospective observational study.

François Cavaille,Mathieu Peretti,Marie-Eve Garcia,Roch Giorgi,Nathalie Ausias,Patrice Vanelle,Fabrice Barlesi,Marc Montana

Real-world efficacy and safety of pembrolizumab in patients with non-small cell lung cancer: a retrospective observational study.

2020

François Cavaille
Mathieu Peretti
Marie-Eve Garcia
Roch Giorgi
Nathalie Ausias
Patrice Vanelle
Fabrice Barlesi
Marc Montana

Background:Pembrolizumab, a humanized immunoglobulin monoclonal antibody directed against the programmed cell death 1 receptor, demonstrated robust efficacy and a manageable safety profile across m...

Keywords:

Oncology
Lung cancer
in patient
Monoclonal antibody
non small cell
Internal medicine
Retrospective cohort study
Pathology
Pembrolizumab
Antibody
safety profile
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations